Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for sexual harassment

Slaoui will return $3.86M to GlaxoSmithKline after his dismissal for sexual harassment

Source: 
Fierce Pharma
snippet: 

Former Operation Warp Speed chief Moncef Slaoui, who GlaxoSmithKline fired last year because of a sexual harassment claim, is returning $3.86 million to the company, according to its annual executive compensation report.

Slaoui, who was chairman of the board of GSK’s Galvani Bioelectronics when he was dismissed in March 2021, agreed to the cash return as the company applied “clawback provisions" under its “recoupment policy.”